Key Insights

Highlights

Success Rate

98% trial completion (above average)

Published Results

13 trials with published results (25%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

1.9%

1 terminated out of 52 trials

Success Rate

97.6%

+11.1% vs benchmark

Late-Stage Pipeline

58%

30 trials in Phase 3/4

Results Transparency

32%

13 of 41 completed with results

Key Signals

13 with results98% success

Data Visualizations

Phase Distribution

43Total
Not Applicable (7)
P 2 (6)
P 3 (13)
P 4 (17)

Trial Status

Completed41
Recruiting5
Unknown3
Withdrawn1
Terminated1
Not Yet Recruiting1

Trial Success Rate

97.6%

Benchmark: 86.5%

Based on 41 completed trials

Clinical Trials (52)

Showing 20 of 20 trials
NCT07140913Phase 3RecruitingPrimary

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

NCT07288320Phase 2Recruiting

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

NCT05766007Recruiting

Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum

NCT06504342Not ApplicableCompleted

Clocks in Sync - Circadian Rhythm and Bipolar Mania

NCT02360267Completed

Pediatric Bipolar Registry

NCT05444907RecruitingPrimary

Deep Brain Stimulation-Induced Mania in Parkinson's Disease

NCT05206747Not ApplicableCompletedPrimary

Ottawa Sunglasses at Night for Mania Study

NCT06748716Not ApplicableNot Yet Recruiting

Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder

NCT05703711Not ApplicableRecruiting

Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa

NCT03573297Phase 3Completed

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

NCT05210062Unknown

Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and the Development of Protective Antibodies

NCT00644800Phase 4Completed

A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

NCT00454883Completed

Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

NCT00917501Phase 2CompletedPrimary

Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania

NCT00732251Phase 4Terminated

Allopurinol Maintenance Study for Bipolar Disorder

NCT01272518Unknown

Assessment of Cardiac Autonomic Behavior in Patients With Mood Disorders

NCT00431184Phase 2Completed

Effects of Pentazocine Versus Lorazepam on Manic Symptoms

NCT00217165Phase 2Completed

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

NCT01015586Phase 4Completed

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

NCT00254488Phase 4Completed

Treatment of Bipolar Mania in Older Adults

Scroll to load more

Research Network

Activity Timeline